Damora Therapeutics, Inc.'s latest marketcap:
As of 06/03/2026, Damora Therapeutics, Inc.'s market capitalization has reached $1.73 B. According to our data, Damora Therapeutics, Inc. is the 7801th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.73 B |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -235,089,000 |
| Shares Out | 60.24 M |
| EPS (ttm) | -24.47 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/12/2026 |
Damora Therapeutics, Inc.'s yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 06/03/2026 | $1.73 B | 4061.68% | 7801 |
| 12/31/2025 | $36.75 M | 500.17% | n/a |
| 12/31/2024 | $6.12 M | -68.63% | n/a |
| 12/29/2023 | $19.52 M | -33.64% | n/a |
| 12/30/2022 | $29.42 M | -61.57% | n/a |
| 12/31/2021 | $76.54 M | n/a |
Company Profile
Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.
It develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications.
The company was founded in 2011 and is headquartered in Copenhagen, Denmark.
Frequently Asked Questions
-
What is Damora Therapeutics, Inc.'s (DMRA) current market cap?As of 06/03/2026, Damora Therapeutics, Inc. (including the parent company, if applicable) has an estimated market capitalization of $1.73 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Damora Therapeutics, Inc. (DMRA) rank globally by market cap?Damora Therapeutics, Inc. global market capitalization ranking is approximately 7801 as of 06/03/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.